#Paracetamol Exports In India

[chemanalystdata]

Para Aminophenol Prices Trend | Pricing | Database | Index | News | Chart

Para Aminophenol Prices, a crucial intermediate in the pharmaceutical and dye industries, has been experiencing significant price fluctuations due to various factors affecting the global market. The prices of para aminophenol are influenced by the cost of raw materials, production capacities, demand and supply dynamics, and regulatory changes. 

Raw material costs are a primary driver of para aminophenol prices. Aniline, a critical raw material used in the production of para aminophenol, has seen its prices fluctuate due to variations in crude oil prices, as aniline is derived from benzene, a petroleum product. Any volatility in the oil market thus directly impacts aniline costs, subsequently affecting para aminophenol prices. Furthermore, environmental regulations in major producing countries, such as China and India, have led to the shutdown of several aniline production units to comply with stricter pollution control norms, reducing supply and driving up prices.

Production capacities and technological advancements also play a significant role in determining para aminophenol prices. Companies with advanced production technologies and larger production capacities can often produce para aminophenol more efficiently and at a lower cost. However, any disruptions in these facilities, whether due to maintenance, regulatory issues, or unforeseen accidents, can lead to supply shortages and price hikes. The concentration of production facilities in certain geographical regions also means that local issues, such as labor strikes, natural disasters, or political instability, can have a global impact on prices.

Get Real Time Prices for Para Aminophenol : https://www.chemanalyst.com/Pricing-data/para-aminophenol-1541

The demand for para aminophenol is closely linked to the pharmaceutical industry, particularly the production of paracetamol. With the ongoing focus on healthcare and increasing incidences of fever and pain-related conditions, the demand for paracetamol continues to rise. This persistent demand exerts continuous upward pressure on para aminophenol prices. Additionally, the dye industry, which uses para aminophenol in the production of various dyes and pigments, also influences its demand and price. While the dye industry may not see as consistent a demand spike as the pharmaceutical sector, any increase in industrial activities can lead to a corresponding rise in para aminophenol prices.

Global trade dynamics and tariffs also affect para aminophenol prices. Trade policies, import-export tariffs, and geopolitical tensions can disrupt the smooth flow of para aminophenol between countries, leading to supply chain disruptions and price volatility. For instance, any trade restrictions imposed by major exporting countries can create supply shortages in importing nations, driving up prices. Conversely, favorable trade agreements can enhance supply availability and stabilize prices.

Regulatory changes and compliance costs in producing countries add another layer of complexity to the pricing of para aminophenol. Stricter environmental and safety regulations can increase production costs, as companies need to invest in cleaner technologies and safer production practices. These additional costs are often passed on to consumers in the form of higher prices. Moreover, regulatory delays in approvals for new production facilities can limit supply growth, further contributing to price increases.

Market speculation and the activities of traders can also lead to price fluctuations. Traders who anticipate future shortages may buy and hold large quantities of para aminophenol, reducing immediate availability and driving up prices. Conversely, if traders expect a decrease in demand or an increase in supply, they may offload their holdings, leading to price drops.

In summary, para aminophenol prices are subject to a complex interplay of factors including raw material costs, production capacities, technological advancements, regulatory changes, demand from the pharmaceutical and dye industries, global trade dynamics, and market speculation. Understanding these factors is crucial for stakeholders in the para aminophenol market to make informed decisions and navigate the volatility effectively. As the global economy continues to evolve, the prices of para aminophenol will likely remain dynamic, reflecting the ongoing changes in supply chain logistics, technological advancements, regulatory landscapes, and market demand.

Get Real Time Prices for Para Aminophenol : https://www.chemanalyst.com/Pricing-data/para-aminophenol-1541

Contact Us:

ChemAnalyst

GmbH - S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Call: +49-221-6505-8833

Email: sales@chemanalyst.com

Website: https://www.chemanalyst.com

[farmson]

Farmson a Leading Exporter of API Paracetamol Manufacturing

Paracetamol is one of the most commonly used pain & fever relievers around the world, and the demand for it has been on the rise.

Farmson is a leading exporter of API Paracetamol due to its high-quality products, large production capacity, necessary certifications, advantageous location, and strong customer focus. Their robust quality management and compliance with international standards ensure consistent, reliable supply, while their strategic location in Western India facilitates efficient raw material procurement.

Farmson's commitment to customer satisfaction has established long-term relationships, contributing to its success as a trusted exporter. For more information visit: https://www.farmson.com/blogs/farmson-a-leading-exporter-of-api-paracetamol/

Related Topics:

Farmson – The Largest Forward & Backward Integrated Manufacturer of API Paracetamol

The Optimal Process of API Paracetamol Manufacturing at Farmson

Pioneering Excellence: A Glimpse into Farmson Pharmaceuticals, a Premier API Paracetamol Manufacturer

The Journey of Farmson Pharmaceuticals: Becoming a Global Leader in API Paracetamol Production

Farmson manufacturing facilities for API Paracetamol

[pilcare-nce]

Doliprane 650mg Tablet Abbott Paracetamol (650mg) Pilcare - Exporter from India

Doliprane 650mg Tablet helps relieve pain and fever by blocking the release of certain chemical messengers responsible for fever and pain. It is used to treat headaches, migraine, toothaches, sore throats, period (menstrual) pains, arthritis, muscle aches, and the common cold.

Doliprane 650mg Tablet, Doliprane 650mg Tablet in India, Doliprane 650mg Pharmaceutical Tablet Exporter from India, Doliprane 650mg Pharmaceutical Tablet in India, Doliprane 650mg Tablet Medicine Exporter in India,

[chemxpert]

Navigating Regulatory Compliance in the Pharmaceutical Industry

Chemxpert Database provides invaluable guidance to paracetamol manufacturers in India, ensuring compliance with stringent regulations. Understand the intricacies of the paracetamol manufacturing process while complying with industry standards. View a comprehensive list of pharmaceutical export companies in India facilitating seamless global trade. Get information about the diverse range of pharmaceutical products exported from India, optimizing your export strategy. Stay ahead of regulatory challenges with this essential resource indispensable for tackling the complex landscape of pharmaceutical compliance.

[impossibledeanmakerwombat]

Acetaminophen API Market: Worldwide Industry Analysis and New Market Opportunities Explored By 2023 to 2032

Acetaminophen API Market: Overview The usage of acetaminophen grade is higher due to its wide utilisation in the drug development process. While it is widely used in the pharmaceutical industry as a pain killer which offers a lucrative opportunity for the growth of the Acetaminophen API market in the forecasted period. Aside from this, the acetaminophen drug is combined with various drug and available in various forms, but it is mostly available in the form of extended-release tablets for showing analgesics effects. But heavy usage of this drug can cause serious adverse effects & can build toxicity which leads to other diseases.

In 2022, the market for acetaminophen API is expected to be worth US$ 1,150.2 Million. The drug is available over the counter (OTC) in the form of extended release tablets that exude analgesic effects. Because of the drug’s usefulness as a palliative in pain relief and in combination with other medications in a variety of medical conditions, the overall demand for acetaminophen is expected to increase at a CAGR of 3.4% between 2022 and 2032, reaching US$ 1,606.86 Million by 2032.

Acetaminophen API (paracetamol), or Tylenol, is used as in the first-line drug therapy in pain conditions. The API when combined with drug shows antipyretic & analgesics effect. Acetaminophen is found in over the counter (OTC) sensitivity drugs, cold meds, sleep medication, pain relievers and so on.

The medication can be administered in patients who are bigoted to salicylates and those with hypersensitive propensities, including bronchial asthmatics. It comes under the NSAIDs (nonsteroidal anti-inflammatory drugs) category because of its capacity to repress the cyclooxygenase (COX) pathways.

The Indian government has confined the export of 27 active pharmaceutical ingredients (APIs) and completed portion drugs made with those APIs because of Covid-19. Johnson and Johnson’s (New Brunswick, NJ, US) Tylenol (acetaminophen/paracetamol) is among the medications whose supply chain will be influenced.

The request will influence worldwide pharmaceutical supply chains. India is a crucial area of pharmaceutical manufacturing for the drugs market in different countries. The nation houses drug manufacturing units possessed by contract fabricating associations (CMOs) and others claimed by local and global biopharma organizations for in-house manufacturing

To remain ahead of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12465

Acetaminophen API Market: Drivers and Restraints:

The easy availability of this drug is boosting the growth of the Acetaminophen API market.  Meanwhile increasing usage of drugs for pain-relieving effects is propelling the growth of the Acetaminophen API market. Moreover, rising incidences of accidents, surgeries are further boosting the Acetaminophen API market.

Moreover, people addiction to using these drugs for rapid pain relief also fuelling the growth of the Acetaminophen API market. Additionally, environmental conditions, lifestyle changes & dietary habits modifications are responsible for a variety of disorders which increases the consumption of these drugs.

However, the excessive dosage can cause toxicity which can lead to serious complications such as liver diseases, fertility issues, carcinogenesis & mutagenesis which can hamper the growth of the Acetaminophen API market.

Acetaminophen API Market: Regional Wise Outlook

Geographically, the Acetaminophen API market is divided into seven regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, China, Japan & the Middle East and Africa.  Asia-Pacific is expected to dominate the global acetaminophen API market followed by North- America & Europe.

Asia-Pacific is dominating the global acetaminophen API market due to higher population rate which led to increased accidental cases, surgeries & various disorders, thus the demand for the drugs is increasing in this region which is boosting the Acetaminophen API regional market. While the increasing healthcare conditions & awareness amongst the people is further fuelling the Acetaminophen API market.

Rapid development & Advancements along with the changing environmental conditions is going to offer a lucrative opportunity for the growth of acetaminophen API market in North America during the forecasted period.

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-12465

Acetaminophen API Market: Key Market Participants

The key participants operating in the global acetaminophen API market identified across the value chain are

BOC Sciences

Tianjin Bofa Acetaminophen

Mallinckrodt plc

 Kemcolour International

Changshu Huagang Acetaminophen

Haohua Industry

Kangle Acetaminophen

Angene International Limited

Anhui BBCA Acetaminophen

Granules India

Hebei Jiheng Acetaminophen

Glosel India Impex Pvt Ltd. from India

 Flare S.A. from Switzerland

Silverline chemicals ltd from India

Emkay Pharma Pvt Ltd from India

Atabay K.S.V.T. from Turkey

Anqiu Lu’An from China

United Pharma Industries Co Ltd from China

Farmson from India

Liaoyuan City Baikang from China

The players working in the worldwide acetaminophen API market are concentrating on the drug discovery i.e. by combining the API with various other extracts for the development of new therapeutic medication which would be helpful in prevention & cure of various disorders. Currently, the company are focusing at the collaborations, mergers & acquisitions with other companies.

Request Customization @  https://www.futuremarketinsights.com/customization-available/rep-gb-12456

Report Highlights:

Detailed overview of the Healthcare market

Changing Acetaminophen API Market dynamics in the industry

Below the Acetaminophen API Market -depth market segmentation

Historical, current, and projected market size in terms of volume and value

Below the Acetaminophen API Market recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Acetaminophen API Market Segmentation:

The global Acetaminophen API market has been segmented based on product form, type, application, end-user and geography.

type

Veterinary Drug Grade

Acetaminophen Grade

end-user

Pharmaceuticals Industry

Research labs

Educational institutes

Others

product form

Tablets (film-coated, extended-release)

Oral Solution

Suppository

Injection

Others

indications

Antipyretic

Analgesics

Others

[worldnewsapp]

According to the head of an Indian drug export committee, India, one of the largest pharmaceutical producers in the world, is prepared to increase fever medication exports to China as that country struggles with an increase in COVID-19 cases. As a result of China's abrupt relaxation of the stringent COVID-19 regulations earlier this month, demand for fever medications and viral test kits surged on the mainland, prompting retailers to impose limits on consumer purchases and pharmaceutical companies to increase production. Sahil Munjal, chairman of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), was reported saying by Reuters, "Marketing queries are coming to drugmakers asking for quotes on ibuprofen and paracetamol." Ibuprofen and paracetamol are currently in low supply in China due to increased demand. Chinese embassy in New Delhi has not yet commented on the matter. According to the foreign ministry of India, one of the largest producers of generic medications worldwide, the nation was prepared to assist China. At a routine news briefing, Arindam Bagchi, a spokesperson for the foreign ministry, stated, "We are keeping an eye on the COVID situation in China. We have always helped other countries as the pharmacy of the world." According to Pharmexcil's most recent annual report, India's pharmaceutical exports to China made up barely 1.4% of all of its exports in 2021–2022. India's major export market for medications is still the United States. On concerns of a COVID-19 revival, shares of Indian pharmaceutical businesses have increased during the last few days. #COVID19 #India #China #Medicines #News #WorldNewsApp Reposted from @timesnow https://www.instagram.com/p/Cmj1WtDoE5n/?igshid=NGJjMDIxMWI=

[sanpdr1994]

Acetaminophen API Market Industry: Segmentation, Targeting, Positioning With Manufacturing Process and CAGR Forecast by 2032

In 2022, the Acetaminophen API Market is expected to be worth US$ 1,150.2 Million. The drug is available over the counter (OTC) in the form of extended release tablets that exude analgesic effects. Because of the drug's usefulness as a palliative in pain relief and in combination with other medications in a variety of medical conditions, the overall demand for acetaminophen is expected to increase at a CAGR of 3.4% between 2022 and 2032, reaching US$ 1,606.86 Million by 2032.

Acetaminophen API Market: Overview

The usage of acetaminophen grade is higher due to its wide utilization in the drug development process. While it is widely used in the pharmaceutical industry as a pain killer which offers a lucrative opportunity for the growth of the Acetaminophen API market in the forecasted period. Aside from this, the acetaminophen drug is combined with various drug and available in various forms, but it is mostly available in the form of extended-release tablets for showing analgesics effects. But heavy usage of this drug can cause serious adverse effects & can build toxicity which leads to other diseases.

For More Information: https://www.futuremarketinsights.com/reports/acetaminophen-api-market

Acetaminophen API (paracetamol), or Tylenol, is used as in the first-line drug therapy in pain conditions. The API when combined with drug shows antipyretic & analgesics effect. Acetaminophen is found in over the counter (OTC) sensitivity drugs, cold meds, sleep medication, pain relievers and so on.

The medication can be administered in patients who are bigoted to salicylates and those with hypersensitive propensities, including bronchial asthmatics. It comes under the NSAIDs (nonsteroidal anti-inflammatory drugs) category because of its capacity to repress the cyclooxygenase (COX) pathways.

The Indian government has confined the export of 27 active pharmaceutical ingredients (APIs) and completed portion drugs made with those APIs because of Covid-19. Johnson and Johnson’s (New Brunswick, NJ, US) Tylenol (acetaminophen/paracetamol) is among the medications whose supply chain will be influenced.

The request will influence worldwide pharmaceutical supply chains. India is a crucial area of pharmaceutical manufacturing for the drugs market in different countries. The nation houses drug manufacturing units possessed by contract fabricating associations (CMOs) and others claimed by local and global biopharma organizations for in-house manufacturing

Acetaminophen API Market: Drivers and Restraints:

The easy availability of this drug is boosting the growth of the Acetaminophen API market.  Meanwhile increasing usage of drugs for pain-relieving effects is propelling the growth of the Acetaminophen API market. Moreover, rising incidences of accidents, surgeries are further boosting the Acetaminophen API market.

Moreover, people addiction to using these drugs for rapid pain relief also fuelling the growth of the Acetaminophen API market. Additionally, environmental conditions, lifestyle changes & dietary habits modifications are responsible for a variety of disorders which increases the consumption of these drugs.

However, the excessive dosage can cause toxicity which can lead to serious complications such as liver diseases, fertility issues, carcinogenesis & mutagenesis which can hamper the growth of the Acetaminophen API market.

Acetaminophen API Market: Regional Wise Outlook

Geographically, the Acetaminophen API market is divided into seven regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, China, Japan & the Middle East and Africa.  Asia-Pacific is expected to dominate the global acetaminophen API market followed by North- America & Europe.

Asia-Pacific is dominating the global acetaminophen API market due to higher population rate which led to increased accidental cases, surgeries & various disorders, thus the demand for the drugs is increasing in this region which is boosting the Acetaminophen API regional market. While the increasing healthcare conditions & awareness amongst the people is further fuelling the Acetaminophen API market.

Rapid development & Advancements along with the changing environmental conditions is going to offer a lucrative opportunity for the growth of acetaminophen API market in North America during the forecasted period.

Acetaminophen API Market: Key Market Participants

The key participants operating in the global acetaminophen API market identified across the value chain are

BOC Sciences

Tianjin Bofa Acetaminophen

Mallinckrodt plc

 Kemcolour International

Changshu Huagang Acetaminophen

Haohua Industry

Kangle Acetaminophen

Angene International Limited

Anhui BBCA Acetaminophen

Granules India

Hebei Jiheng Acetaminophen

Glosel India Impex Pvt Ltd. from India

 Flare S.A. from Switzerland

Silverline chemicals ltd from India

Emkay Pharma Pvt Ltd from India

Atabay K.S.V.T. from Turkey

Anqiu Lu’An from China

United Pharma Industries Co Ltd from China

Farmson from India

Liaoyuan City Baikang from China

The players working in the worldwide acetaminophen API market are concentrating on the drug discovery i.e. by combining the API with various other extracts for the development of new therapeutic medication which would be helpful in prevention & cure of various disorders. Currently, the company are focusing at the collaborations, mergers & acquisitions with other companies.

Report Highlights:

Detailed overview of the Healthcare market

Changing Acetaminophen API Market dynamics in the industry

Below the Acetaminophen API Market -depth market segmentation

Historical, current, and projected market size in terms of volume and value

Below the Acetaminophen API Market recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Acetaminophen API Market Segmentation:

The global Acetaminophen API market has been segmented based on product form, type, application, end-user and geography.

Type

Veterinary Drug Grade

Acetaminophen Grade

End-User

Pharmaceuticals Industry

Research labs

Educational institutes

Others

Product Form

Tablets (film-coated, extended-release)

Oral Solution

Suppository

Injection

Others

Indications

Antipyretic

Analgesics

Others

[sounmashnews]

[ad_1] The World Health Organisation stated it's investigating an Indian cough syrupNew Delhi: The World Health Organization (WHO) issued an alert Wednesday over 4 cough and chilly syrups made by Maiden Pharmaceuticals in India, warning they may very well be linked to the deaths of 66 youngsters in The Gambia.The UN well being company additionally cautioned that the contaminated medicines might have been distributed outdoors of the West African nation, with international publicity "possible."WHO chief Tedros Adhanom Ghebreyesus informed reporters that the 4 chilly and cough syrups in query "have been potentially linked with acute kidney injuries and 66 deaths among children.""The loss of these young lives is beyond heartbreaking for their families.""The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited, in India. WHO is conducting further investigation with the company and regulatory authorities in India"-@DrTedroshttps://t.co/PceTWc836t— World Health Organization (WHO) (@WHO) October 5, 2022Tedros stated that WHO was additionally "conducting further investigation with the company and regulatory authorities in India."According to the medical product alert issued by WHO Wednesday, the 4 merchandise are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup."To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products," the alert stated, including that laboratory evaluation of samples of the merchandise "confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants."Those substances are poisonous to people and could be deadly, it stated, including that the poisonous impact "can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state and acute kidney injury which may lead to death."The Gambia's well being ministry requested hospitals final month to cease utilizing a syrup paracetamol, pending the end result of an investigation, after no less than 28 youngsters died of kidney failure.WHO stated that info acquired from India's Central Drugs Standard Control Organisation indicated that the producer had solely equipped the contaminated medicines to The Gambia."However, the supply of these products through informal or unregulated markets to other countries in Africa, cannot be ruled out," the UN company stated in an e-mail."In addition, the manufacturer may have used the same contaminated material in other products and distributed them locally or exported," it warned."Global exposure is therefore possible."Tedros urged warning, calling on all international locations to work to "detect and remove these products from circulation to prevent further harm to patients."The Gambian well being ministry's recommendation on syrup paracetamol was issued on September 9, a month after investigators reported the loss of life of no less than 28 youngsters aged 5 months to 4 years from acute renal failure.The investigation had been opened on July 19. No particulars got as to when the kids died.(Except for the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.) [ad_2] Source link

[kppanchal]

Paracetamol Powder manufacture and Exporter in India | acetaminophen powder & mebendazole powder supplier | Farmson

Farmson is the manufacturer and exporter of paracetamol drugs such as paracetamol Ip, paracetamol Bp, granules, paracetamol crystal and many more. We’re supplying mebendazole and acetaminophen powder across India. Visit our site and buy our products with more details.

[harpianews]

Sudden ban on medical exports forces companies to look abroad

Sudden ban on medical exports forces companies to look abroad

Ad-hoc export restrictions on essential medical supplies, especially since the start of the pandemic early last year, have led many Indian manufacturers and suppliers of these goods to explore the option of setting up alternative manufacturing bases outside the country to serve their customers. motivating to apply. Hindustan Syringes & Medical Devices (HMD), the country’s largest syringe…

[weelectronicstudentreviewstuff]

India supplied paracetamol, hydroxychloroquine to over 120 countries in last 2 mths: Goyal Image Source : AP India supplied paracetamol, hydroxychloroquine to over 120 countries in last 2 mths…

[farmson]

Why is Farmson a Leading Exporter of API Paracetamol

India has long been a major player in the global pharmaceutical industry, with a thriving domestic market and a reputation for producing high-quality, affordable drugs. However, like many other countries, India has historically relied on imports for many of the raw materials used in drug manufacturing. In recent years, there has been a push to increase self-reliance in the pharmaceutical industry, and Farmson Pharmaceutical had already embarked on this path long back leading the charge when it comes to Paracetamol API manufacturing.

For more information visit: https://www.farmson.com/blogs/self-reliance-in-paracetamol-api-manufacturing/

[medicircle-blog]

India decides to relax curb on export of paracetamol based drugs #Paracetamol #India #Export #Relaxation #medicircle https://bit.ly/34N8sd8 https://www.instagram.com/p/B_E88GqJouL/?igshid=1175uifwy9me0

[biglittlecrane]

90% of our pharmaceuticals are produced in China. So today our President made a deal with Kodak...

Ronna McDaniel RetweetedGOP@GOP·3h

“Today, my Administration has taken a momentous step towards achieving American pharmaceutical independence.” -@realDonaldTrump

Column: With most drug ingredients coming from China, FDA says shortages have begun

“Acetaminophen, also known as paracetamol, is America’s most widely used drug ingredient, found not just in namesake pills but also as a component of hundreds of cold, flu and allergy remedies.

A recent study determined that 84% of the world’s supply of acetaminophen comes from China and India, with China accounting for nearly two-thirds of the total.

Then there are all the inactive ingredients in the BJ’s acetaminophen. These include various components that go into making a pill a pill, such as croscarmellose sodium, crospovidone and assorted colorings, all of which almost certainly come from overseas factories, primarily in China.“

“About 90% of the core components of leading antibiotics such as amoxicillin and penicillin come from China.”

“‘Companies have business continuity plans and I am sure are working hard to respond,’ said Ravi Anupindi, a professor of operations research and management at the University of Michigan.He added, however: ‘They need to reduce their dependence on China.’”

https://www.latimes.com/business/story/2020-02-28/column-coronavirus-china-drugs

‘Chinese state media have raised the specter of using Beijing’s pharmaceutical leverage to block critical components and supplies for dependent U.S. drug companies and send America into “the hell of a novel coronavirus epidemic.”’

https://www.washingtontimes.com/news/2020/mar/17/china-threatens-restrict-critical-drug-exports-us/

[esytes69]

New Post has been published on https://acqro.in/brazil-cites-sanjeevani-booti-from-ramayan-in-request-to-india-for-hydroxychloroquine/

Brazil cites 'Sanjeevani Booti' from Ramayan in request to India for Hydroxychloroquine

Amid coronavirus cases rising worldwide, Brazilian President Jair M Bolsonaro has written to Prime Minister Narendra Modi on with references to Ramayana & Bible

Amid coronavirus cases rising worldwide, Brazilian President Jair M Bolsonaro has written to Prime Minister Narendra Modi on with references to Ramayana and The Bible, as per reports that surfaced on social media. Reports claimed that Bolsanaro while requesting India for Hydroxychloroquine has mentioned Lord Hanuman and ‘sanjeevani booti‘ that was used to save Lord Lakshman, brother of Lord Rama. It also stated that ‘Jesus healed those who were sick’, in the same way, India and Brazil will come together and ‘share blessings for the sake of all people.’

Meanwhile, US President Donald Trump after his request to India to release Hydroxychloroquine, warned of ‘retaliation’, if New Delhi stops the supply. Amidst an intense debate on the side effects of hydroxychloroquine in the treatment of COVID-19, Trump has been actively promoting the drug as an option when there is no viable treatment for the dreaded virus. India on Tuesday clarified that it will licence paracetamol and Hydroxychloroquine in appropriate quantities to all neighbouring countries and to some nations who have been particularly badly affected by the pandemic.

Brazilian President Bolsonaro too had a telephonic conversation with PM Modi. They discussed the global situation in the wake of the pandemic. After PM Modi, Bolsonaro also tweeted in Portuguese about his discussion with the Prime Minister, saying he requested the latter for support in the continuity of the supply of pharmaceutical inputs for the production of hydroxychloroquine. Members of the SAARC bloc and Indonesia and the UAE have also requested India to lift the export ban on hydroxychloroquine, as they stare at a shortage of the drug primarily used for rheumatoid arthritis and long-term autoimmune disease lupus. According to reports, several other European countries have also requested India for the supply of hydroxychloroquine. In the last few days, PM Modi has held a series of telephonic conversations over the COVID-19 pandemic with several world leaders, including Israeli Prime Minister Benjamin Netanyahu, German Chancellor Angela Merkel, UK’s Prince Charles, French President Emmanuel Macron and Kuwaiti Prime Minister Sheikh Sabah Al-Khaled Al-Hamad Al-Sabah.  

[tajpharma2022]

#paracetamolinfusion #paracetamol #infusion #headache #migraine #nervepain #toothache #sorethroat #periodpains #arthritis #musclesaches #mentrualpains

Searching for Pharmaceutical Infusion Range ? For Sales— 1-800-222-434/825 — Intravenous paracetamol — Paracetamol Infusion at Best Price in India #InfusionRange #Paracetamol #PharmaceuticalProduct

*Latest DCGI Molecules *High Margin Returns *100% Quality Products

For Sales— 1-800-222-434/825

#tajpharmaceuticals

* LOWEST PRICES * GET HIGH MARGIN RETURNS * TIMELY DELIVERY * Latest DCGI Molecules * High Margin Returns * 100% Quality Products

For Sales— 1-800-222-434/825

#tajpharmaceuticals

* Lowest price * GMP-WHO Approved * 100% Quality Assurance * TIMELY DELIVERY * Latest DCGI Molecules * High Margin Returns

* AUTO ASSIGN LEADS TO EXECUTIVE * SMART AUTO FOLLOW UP

For Sales— 1-800-222-434/825

#tajpharmaceuticals

For best Quality Range of #Pharmaceutical #Infusion !!

* Lowest price * GMP-WHO Approved * 100% Quality Assurance * TIMELY DELIVERY * Latest DCGI Molecules * High Margin Returns

* AUTO ASSIGN LEADS TO EXECUTIVE * SMART AUTO FOLLOW UP

For Sales— 1-800-222-434/825

#tajpharmaceuticals

#ThirdPartyContractManufacturing, #supplying, #trading and exporting a wide range of #PharmaceuticalProducts (Tablets, Capsules, Injectables, #External applications.

* AUTO ASSIGN LEADS TO EXECUTIVE * SMART AUTO FOLLOW UP

For Sales— 1-800-222-434/825

#tajpharmaceuticals

#TajPharmaceuticals markets several #PharmaceuticalProducts that address the therapeutic areas like #InternalMedicine, #cardiology, #diabetology, #neurology, #urology, #gynaecology, #AntiBacterial etc.

* AUTO ASSIGN LEADS TO EXECUTIVE * SMART AUTO FOLLOW UP

For Sales— 1-800-222-434/825

#tajpharmaceuticals